TLR8 and metastatic malignant neoplasm in the lymph nodes: Patients with high cytoplasmic TLR8 intensity in lymph node metastases had received more somatostatin analogue treatment compared to low intensity group (72.2% vs. 50.0%, p = 0.048) (Table 8).